Drugs.com Releases Q3 Sales for Top 100 U.S. Drugs: Singulair Drops But...
Drugs.com Releases Q3 Sales for Top 100 U.S. Drugs: Singulair Drops But Nexium and Abilify Remain the Leading Brands Drugs.com, the leading online clinical drug resource, today released third quarter...
View ArticleDrugs.com Releases Q3 Sales for Top 100 U.S. Drugs: Singulair Drops But...
Drugs.com Releases Q3 Sales for Top 100 U.S. Drugs: Singulair Drops But Nexium and Abilify Remain the Leading Brands Drugs.com, the leading online clinical drug resource, today released third quarter...
View ArticleDrugs.com Releases Q3 Sales for Top 100 U.S. Drugs: Singulair Drops But...
Drugs.com Releases Q3 Sales for Top 100 U.S. Drugs: Singulair Drops But Nexium and Abilify Remain the Leading Brands Drugs.com, the leading online clinical drug resource, today released third quarter...
View ArticleDrugs.com Releases Q3 Sales for Top 100 U.S. Drugs: Singulair Drops But...
Drugs.com Releases Q3 Sales for Top 100 U.S. Drugs: Singulair Drops But Nexium and Abilify Remain the Leading Brands Drugs.com, the leading online clinical drug resource, today released third quarter...
View ArticleClik here to view.
Pfizer Acquires NextWave Pharmaceuticals, Inc.
Pfizer Acquires NextWave Pharmaceuticals, Inc. Includes exclusive North American commercialization rights to recently approved Quillivant XR™ (methylphenidate hydrochloride), the first once-daily...
View ArticleClik here to view.
Pfizer Acquires NextWave Pharmaceuticals, Inc.
Pfizer Acquires NextWave Pharmaceuticals, Inc. Includes exclusive North American commercialization rights to recently approved Quillivant XR™ (methylphenidate hydrochloride), the first once-daily...
View ArticleClik here to view.
Pfizer Acquires NextWave Pharmaceuticals, Inc.
Pfizer Acquires NextWave Pharmaceuticals, Inc. Includes exclusive North American commercialization rights to recently approved Quillivant XR™ (methylphenidate hydrochloride), the first once-daily...
View ArticleClik here to view.
Pfizer Acquires NextWave Pharmaceuticals, Inc.
Pfizer Acquires NextWave Pharmaceuticals, Inc. Includes exclusive North American commercialization rights to recently approved Quillivant XR™ (methylphenidate hydrochloride), the first once-daily...
View ArticleClik here to view.
Pfizer Acquires NextWave Pharmaceuticals, Inc.
Pfizer Acquires NextWave Pharmaceuticals, Inc. Includes exclusive North American commercialization rights to recently approved Quillivant XR™ (methylphenidate hydrochloride), the first once-daily...
View ArticleClik here to view.
Pfizer Acquires NextWave Pharmaceuticals, Inc.
Pfizer Acquires NextWave Pharmaceuticals, Inc. Includes exclusive North American commercialization rights to recently approved Quillivant XR™ (methylphenidate hydrochloride), the first once-daily...
View ArticleClik here to view.
Pfizer Acquires NextWave Pharmaceuticals, Inc.
Pfizer Acquires NextWave Pharmaceuticals, Inc. Includes exclusive North American commercialization rights to recently approved Quillivant XR™ (methylphenidate hydrochloride), the first once-daily...
View ArticleClik here to view.
Merck Initiates Phase II/III Study of Investigational BACE Inhibitor,...
Merck Initiates Phase II/III Study of Investigational BACE Inhibitor, MK-8931, for Treatment of Alzheimer’s Disease Phased study to evaluate safety and efficacy of MK-8931 in patients with...
View ArticleClik here to view.
Merck and GE Healthcare Collaborate on Use of Imaging Biomarkers for...
Merck and GE Healthcare Collaborate on Use of Imaging Biomarkers for Investigational BACE inhibitor Clinical Development Program WHITEHOUSE STATION, N.J. & PRINCETON, N.J.–(BUSINESS WIRE)–Dec 18,...
View ArticleClik here to view.
Orion and Mylan settle patent dispute over the proprietary drug Comtan
Orion and Mylan settle patent dispute over the proprietary drug Comtan Orion Corporation (“Orion”) and Mylan Pharmaceuticals Inc. (“Mylan”) have executed a settlement agreement on lawsuit filed by...
View ArticleGilead Sciences, Inc. Praised for Commitment on Chimpanzee Research
Gilead Sciences, Inc. Praised for Commitment on Chimpanzee Research The Humane Society of the United States welcomes the pharmaceutical company’s decision
View ArticleClik here to view.
Merck Provides Update on Next Steps for Tredaptive (extended-release...
Merck Provides Update on Next Steps for Tredaptive (extended-release niacin/laropiprant) WHITEHOUSE STATION, N.J.–(BUSINESS WIRE)–Jan 11, 2013 – Merck (NYSE: MRK), known as MSD outside of the United...
View ArticlePfizer Wins RAPAMUNE Patent Case in Delaware District Court
Pfizer Wins RAPAMUNE Patent Case in Delaware District Court NEW YORK–(BUSINESS WIRE)–Jan 31, 2013 – Pfizer Inc. said today that the United States District Court for the District of Delaware ruled that...
View ArticleClik here to view.
Merck Statement on Venezuelan Currency Devaluation
Merck Statement on Venezuelan Currency Devaluation Merck Confirms 2013 Full-Year Guidance and Provides Guidance on First Quarter WHITEHOUSE STATION, N.J.–(BUSINESS WIRE)–Feb 13, 2013 – Merck, known as...
View ArticleClik here to view.
Merck Resolves Securities Class-Action Lawsuits Related to the ENHANCE Trial
Merck Resolves Securities Class-Action Lawsuits Related to the ENHANCE Trial The Company Records $493 Million Charge Reducing 2012 GAAP Results WHITEHOUSE STATION, N.J., February 14, 2013 –(BUSINESS...
View ArticleClik here to view.
Merck Resolves Securities Class-Action Lawsuits Related to the ENHANCE Trial
Merck Resolves Securities Class-Action Lawsuits Related to the ENHANCE Trial The Company Records $493 Million Charge Reducing 2012 GAAP Results WHITEHOUSE STATION, N.J., February 14, 2013 –(BUSINESS...
View ArticleClik here to view.
US Court of Appeals Affirms Decision Finding Seroquel XR Formulation Patent...
US Court of Appeals Affirms Decision Finding Seroquel XR Formulation Patent Valid and Infringed Friday, 15 February 2013 AstraZeneca today announced that, on 14 February 2013, the United States Court...
View ArticleClik here to view.
US Court of Appeals Affirms Decision Finding Seroquel XR Formulation Patent...
US Court of Appeals Affirms Decision Finding Seroquel XR Formulation Patent Valid and Infringed Friday, 15 February 2013 AstraZeneca today announced that, on 14 February 2013, the United States Court...
View ArticleClik here to view.
Merck and Samsung Bioepis Enter Biosimilars Development and Commercialization...
Merck and Samsung Bioepis Enter Biosimilars Development and Commercialization Agreement WHITEHOUSE STATION, N.J. & SEOUL, South Korea–(BUSINESS WIRE)–Merck, (NYSE: MRK) known as MSD outside the...
View ArticleClik here to view.
FDA Approves Generic Suboxone
FDA Approves Generic Suboxone Feb. 25, 2013 — The United States Food and Drug Administration (FDA) has approved generic versions of Reckitt Benckiser Healthcare’s Suboxone sublingual tablets....
View ArticleClik here to view.
United States Patent & Trademark Office Grants Pfizer Reissue Patent For...
United States Patent & Trademark Office Grants Pfizer Reissue Patent For Celebrex® (celecoxib capsules) NEW YORK–(BUSINESS WIRE)–Mar 5, 2013 – Pfizer Inc. announced today that the United States...
View ArticleClik here to view.
Merck Announces Appointment of Roger M. Perlmutter, M.D., Ph.D., As President...
Merck Announces Appointment of Roger M. Perlmutter, M.D., Ph.D., As President of Merck Research Laboratories; Peter S. Kim, Ph.D., to Retire WHITEHOUSE STATION, N.J.–(BUSINESS WIRE)–Mar 7, 2013 – Merck...
View Article
